AtriCure Inc at Needham Healthcare Conference Transcript
Audio in progress.
Medical device analyst here at Needham and Company. I have got AtriCure on stage with me: Mike Carrel, who is the CEO, to my left, and to his left is Andy Wade, CFO. So we are going to do another fireside chat. I will just start with the questions, kind of broken out by business revenue category here.
So I want to start with the open heart ablation category. So the Society guidelines were changed in early 2017. It's been almost I guess over two years now. So looking back, what do you think the impact has been? And it seems like it's provided a bit of a tailwind and do you think that will continue?
Well, first, thanks for having us here and for the coverage that you have given. Really appreciate it, and appreciate the day that we have had here. So it has been a great conference so far for us.
The open business and the guidelines, the guidelines have been incredibly helpful because they
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |